Indirect calorimeter Market size is expected to show steady growth during the forecast timeframe of 2023-2032, given the rising preference for non-invasive surgical procedures. The prevalence of obesity has increased substantially in recent years and might be one of the major factors driving the market expansion. According to data by NHS Digital, in 2021, nearly 26% of adults in England were obese. These factors are predicted to enhance the demand for indirect calorimeters.
Since these calorimeters, also known as metabolic carts, offer information regarding parameters, such as nutritional requirements, metabolism rate, and aerobic fitness, dieticians and nutritionists can better understand a patient’s specific nutritional needs. These advantages have prompted healthcare establishments to use these devices to improve their patient’s quality of life.
Based on end-user, global indirect calorimeter market is segmented into hospitals, diagnostic centers, research institutes, and others. The market size from the research institute segment is anticipated to record a steady CAGR through 2032. Rising consumption of processed foods and its connection with chronic health conditions has boosted the demand for nutrition-based research and clinical trials. Several R&D initiatives are receiving ample financial support to improve the quality of medical facilities and enhance the overall patient outcome.
For instance, in January 2022, the U.S. National Institutes of Health (NIH) awarded funds worth USD 170 million over the next five years to help research institutes and clinics across the country develop algorithms that predict individual responses to dietary routines and food choices. This has bolstered the development of technologically advanced metabolic carts that are affordable, portable, and user-friendly and can support clinical research applications. These factors will stimulate the market progress.
Based on product, indirect calorimeter market is bifurcated into standalone and portable. The market revenue from the portable product segment may register a considerable CAGR through 2032, driven by the growing number of ICU admissions. According to the U.S. Society of Critical Care Medicine (SCCM), more than 5 million patients in the country are admitted in ICUs every year.
Healthcare practitioners are extensively using portable indirect calorimeters to accurately determine the energy requirements of ICU patients. These devices play a vital role in ensuring that a patient is not overfed or underfed as their energy needs can increase due to sepsis, traumatic injuries, surgery, and burns. Such beneficial features will amplify the industry growth during the analysis timeframe.
Hospitals are projected to capture a sizeable share of indirect calorimeter market by 2032. Rising burn injuries has boosted the average patient footfall across hospitals. According to the U.S. National Fire Protection Association (NFPA), 1.3 million fires occurred in 2021, with 3,800 casualties and 14,700 injuries caused by these accidents. Patients with burn injuries rely on these units to meet their changing caloric requirements, thereby driving the market outlook.
Asia Pacific indirect calorimeter market share will exhibit notable expansion during the forecast timeline as the incidence of obesity and other chronic diseases is increasing in countries, such as China. According to the Chinese Nutrition Society’s Dietary Guidelines for Chinese Residents 2022, 50.7% of adults in the nation were overweight, with 16.4% of them coming in the category of ‘obese’. These factors have made people more conscious about their food choices. They are also keeping a close track of their calorie intake, thereby augmenting the adoption of indirect calorimeters.
COSMED, ParvoMedics, MGC Diagnostics (formerly known as Angeion Corporation), Microlife USA, and KORR Medical Technologies are a few of the eminent manufacturers of indirect calorimeters. Corporate strategies, such as partnerships, mergers & acquisitions, and R&D initiatives are helping these organizations secure a dominant position in the market.